The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells
van Deventer, Hendrik W, Burgents, Joseph E, Wu, Qing Ping, Woodford, Rita-Marie T, Brickey, W June, Allen, Irving C, McElvania-Tekippe, Erin, Serody, Jonathan S, Ting, Jenny P-Y
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Published in Cancer research (Chicago, Ill.) (15.12.2010)
Get full text
Journal Article
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
Grünwald, Viktor, Powles, Thomas, Eto, Masatoshi, Kopyltsov, Evgeny, Rha, Sun Young, Porta, Camillo, Motzer, Robert, Hutson, Thomas E, Méndez-Vidal, María José, Hong, Sung-Hoo, Winquist, Eric, Goh, Jeffrey C, Maroto, Pablo, Buchler, Tomas, Takagi, Toshio, Burgents, Joseph E, Perini, Rodolfo, He, Cixin, Okpara, Chinyere E, McKenzie, Jodi, Choueiri, Toni K
Published in Frontiers in oncology (16.08.2023)
Published in Frontiers in oncology (16.08.2023)
Get full text
Journal Article
Corrigendum: Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
Grünwald, Viktor, Powles, Thomas, Eto, Masatoshi, Kopyltsov, Evgeny, Rha, Sun Young, Porta, Camillo, Motzer, Robert, Hutson, Thomas E, Méndez-Vidal, María José, Hong, Sung-Hoo, Winquist, Eric, Goh, Jeffrey C, Maroto, Pablo, Buchler, Tomas, Takagi, Toshio, Burgents, Joseph E, Perini, Rodolfo, He, Cixin, Okpara, Chinyere E, McKenzie, Jodi, Choueiri, Toni K
Published in Frontiers in oncology (01.03.2024)
Published in Frontiers in oncology (01.03.2024)
Get full text
Journal Article
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma – Authors' reply
Powles, Thomas, Burgents, Joseph E, Xu, Lei, Choueiri, Toni K
Published in The lancet oncology (01.01.2023)
Published in The lancet oncology (01.01.2023)
Get full text
Journal Article
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
Choueiri, Toni K., Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Tom, Symeonides, Stefan N., Hajek, Jaroslav, Chang, Yen-Hwa, Lee, Jae-Lyun, Sarwar, Naveed, Haas, Naomi B., Gurney, Howard, Sawrycki, Piotr, Mahave, Mauricio, Gross-Goupil, Marine, Zhang, Tian, Burke, John M., Doshi, Gurjyot, Melichar, Bohuslav, Kopyltsov, Evgeniy, Alva, Ajjai, Oudard, Stephane, Topart, Delphine, Hammers, Hans, Kitamura, Hiroshi, McDermott, David F., Silva, Adriano, Winquist, Eric, Cornell, Jerry, Elfiky, Aymen, Burgents, Joseph E., Perini, Rodolfo F., Powles, Thomas
Published in The New England journal of medicine (18.04.2024)
Published in The New England journal of medicine (18.04.2024)
Get full text
Journal Article
Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells
Coghill, James M., Carlson, Michael J., Panoskaltsis-Mortari, Angela, West, Michelle L., Burgents, Joseph E., Blazar, Bruce R., Serody, Jonathan S.
Published in Blood (10.06.2010)
Published in Blood (10.06.2010)
Get full text
Journal Article
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice
Moran, Timothy P, Burgents, Joseph E, Long, Brian, Ferrer, Ivana, Jaffee, Elizabeth M, Tisch, Roland M, Johnston, Robert E, Serody, Jonathan S
Published in Vaccine (04.09.2007)
Published in Vaccine (04.09.2007)
Get full text
Journal Article
The immunosuppressive tumor environment is the major impediment to successful therapeutic vaccination in Neu transgenic mice
Burgents, Joseph E, Moran, Timothy P, West, Michelle L, Davis, Nancy L, Johnston, Robert E, Serody, Jonathan S
Published in Journal of immunotherapy (1997) (01.06.2010)
Published in Journal of immunotherapy (1997) (01.06.2010)
Get more information
Journal Article
Effects of Hypoxia and Hypercapnic Hypoxia on the Localization and the Elimination of Vibrio campbellii in Litopenaeus vannamei, the Pacific White Shrimp
Burgents, Joseph E., Burnett, Karen G., Burnett, Louis E.
Published in The Biological bulletin (Lancaster) (01.06.2005)
Published in The Biological bulletin (Lancaster) (01.06.2005)
Get full text
Journal Article
Expression Profiles of Na+,K+-ATPase during Acute and Chronic Hypo-Osmotic Stress in the Blue Crab Callinectes sapidus
Lovett, Donald L., Verzi, Michael P., Burgents, Joseph E., Christopher A. Tanner, Krzysztof Glomski, Joan J. Lee, Towle, David W.
Published in The Biological bulletin (Lancaster) (01.08.2006)
Published in The Biological bulletin (Lancaster) (01.08.2006)
Get full text
Journal Article
Pembrolizumab plus lenvatinib vs nivolumab plus cabozantinib in patients with metastatic renal cell carcinoma: A matching adjusted indirect comparison (MAIC)
Rane, Pratik, Walton, Laura, Schmidinger, Manuela, Peer, Avivit, Mt-Isa, Shahrul, Burgents, Joseph E., Sundaram, Murali
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Pembrolizumab plus lenvatinib (P+L) versus alternative therapies in first-line (1L) advanced renal cell carcinoma (aRCC) by IMDC risk status: A network meta-analysis (NMA)
Rane, Pratik, Yan, Kevin, Schmidinger, Manuela, Peer, Avivit, Druyts, Eric, Burgents, Joseph E., Sundaram, Murali
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Pembrolizumab plus lenvatinib (P+L) versus alternate therapies in first-line (1L) for advanced renal cell carcinoma (aRCC): A network meta-analysis (NMA)
Yan, Kevin, Rane, Pratik, Schmidinger, Manuela, Peer, Avivit, Druyts, Eric, Burgents, Joseph E., Sundaram, Murali
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Pembrolizumab (pembro) plus enzalutamide (enza) and androgen deprivation therapy (ADT) for patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC): The phase III KEYNOTE-991 study
Gratzke, Christian, Niu, Cuizhen, Poehlein, Christian Heinrich, Burgents, Joseph E.
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
Phase III study of pembrolizumab (pembro) plus enzalutamide (enza) and androgen deprivation therapy (ADT) for patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC): KEYNOTE-991
Gratzke, Christian, Burgents, Joseph E, Niu, Cuizhen, Poehlein, Christian Heinrich, Drake, Charles G.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Genomic/genetic testing patterns for patients with metastatic castrate-resistant prostate cancer: Results from a real-world study in the United States
Leith, Andrea, Ribbands, Amanda, Last, Matthew, Gayle, Alicia, Payne, Sarah, McCrea, Charles, Yang, Lingfeng, Burgents, Joseph E., Ghate, Sameer
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
Subgroup analyses of efficacy outcomes by baseline tumor size in the phase 3, open-label CLEAR trial
Grünwald, Viktor, Motzer, Robert J., Haanen, John B. A. G., Schmidinger, Manuela, Staehler, Michael D., Goh, Jeffrey C., Voog, Eric, Climent, Miguel Ángel, George, Saby, Burgents, Joseph E., Xie, Ran, McKenzie, Jodi, Porta, Camillo
Published in Journal of clinical oncology (01.02.2024)
Published in Journal of clinical oncology (01.02.2024)
Get full text
Journal Article
Phase 3 LITESPARK-022: Pembrolizumab (pembro) plus hypoxia-inducible factor 2α (HIF-2α) inhibitor belzutifan as adjuvant treatment for clear cell renal cell carcinoma (ccRCC)
Choueiri, Toni K., Bedke, Jens, Karam, Jose A., McKay, Rana R., Motzer, Robert J., Pal, Sumanta Monty, Suárez, Cristina, Uzzo, Robert, Liu, Hong, Burgents, Joseph E., Sharma, Manish, Powles, Thomas
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article